Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

15

Revenue 2014

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

BMS data add to checkpoint inhibitor combo confusion

BMS data add to checkpoint inhibitor combo confusion

Bristol-Myers Squibb has reported mixed results from a trial of its two checkpoint inhibitors - Opdivo and Yervoy - in metastatic renal cell carcinoma (RCC), a form of kidney cancer.

NICE expands Merck KGaA’s Erbitux reach

NICE expands Merck KGaA’s Erbitux reach Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) recently claimed the title of the first immuno-oncology drug approved to treat adults with SCCHN in the EU, however Opdivo failed to impress

Biotecnol taps into Cancer Research UK network for first trial

Biotecnol taps into Cancer Research UK network for first trial The first immuno-oncology antibodies such as Bristol-Myers Squibb's Opdivo (nivolumab) and Merck &Co's Keytruda (pembrolizumab) are already racking up blockbuster sales, and new approaches, including CAR-T

Kite starts EU trial of lead CAR-T therapy

Kite starts EU trial of lead CAR-T therapy The company hired Chris Nowers - formerly head of immuno-oncology and haematology at Bristol-Myers Squibb (BMS) in France, as head of Europe to spearhead the roll-out of the therapy

BMS boosts immuno-oncology with $2.3bn IFM buy

BMS boosts immuno-oncology with $2.3bn IFM buy Bristol-Myers Squibb is paying a sizeable $300m upfront for IFM Therapeutics, getting its hands on two cancer programmes that will flesh out its cancer immunotherapy portfolio.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Bristol-Myers Squibb
Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA
US revenue 2014
1: Gilead Sciences
2: Johnson & Johnson
3: Pfizer
4: Roche
5: Novartis
6: Amgen
7: Merck & Co.
8: Sanofi
9: AbbVie
10: Actavis
11: AstraZeneca
12: GlaxoSmithKline
13: Lilly
14: Bristol-Myers Squibb
15: Novo Nordisk
Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte
Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda
CNS revenue 2014
1: Pfizer
2: Biogen Idec
3: Novartis
4: Otsuka
5: Teva
6: Johnson & Johnson
7: Lilly
8: Merck KGaA
9: AstraZeneca
10: Shire
11: Bristol-Myers Squibb
12: UCB
13: Lundbeck
14: Eisai
15: GlaxoSmithKline
16: Sanofi
17: Mylan
18: Indivior
19: Actavis
20: Bayer
Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company
Biologic revenue 2014
1: Roche
2: Amgen
3: Novo Nordisk
4: AbbVie
5: Sanofi
6: Johnson & Johnson
7: Pfizer
8: Merck & Co.
9: Lilly
10: Biogen Idec
11: Merck KGaA
12: GlaxoSmithKline
13: Bristol-Myers Squibb
14: Novartis
15: Bayer

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Unfolding the story as two great brands unite for the good of patients
A case study by Create Health...
Innovation Hack
Hacking Innovation
RB’s Lions Health event saw teams compete to protect children in China from air pollution...
Being social - harnessing the power of social media
...

Infographics